Trump Administration Reclassifies State-Licensed Medical Marijuana to Schedule III
Select a version of the text written from a presumed ideological perspective. This is not the original text, but a hypothetical version — how someone with that viewpoint might have phrased it. Tapping the current version again will return to the original or select cleaned version.
The Justice Department has reclassified state-licensed medical marijuana from Schedule I to Schedule III, acknowledging its medical use and reducing regulatory barriers.
The Justice Department announced on Thursday the reclassification of state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. This change acknowledges the medical use of cannabis and reduces regulatory barriers, facilitating research and allowing businesses to claim tax deductions.
Acting Attorney General Todd Blanche stated, "The Department of Justice is delivering on President Trump’s promise to expand Americans’ access to medical treatment options."
The reclassification does not legalize marijuana federally but aligns with President Trump's December executive order directing the Justice Department to expedite the process. The administration plans further reclassification efforts, with broader hearings scheduled for June.
Critics, such as Kevin Sabet of Smart Approaches to Marijuana, argue that the tax relief benefits large cannabis companies and sends a mixed message about the drug's risks. Supporters hail it as the most significant federal step for cannabis reform in decades.